Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.

MLA

Ardeshirrouhanifard, Shirin, et al. “Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.” Ear and Hearing, vol. 43, no. 3, May 2022, pp. 794–807. EBSCOhost, https://doi.org/10.1097/AUD.0000000000001172.

APA

Ardeshirrouhanifard, S., Fossa, S. D., Huddart, R., Monahan, P. O., Fung, C., Song, Y., Dolan, M. E., Feldman, D. R., Hamilton, R. J., Vaughn, D., Martin, N. E., Kollmannsberger, C., Dinh, P., Einhorn, L., Frisina, R. D., & Travis, L. B. (2022). Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments. Ear and Hearing, 43(3), 794–807. https://doi.org/10.1097/AUD.0000000000001172

Chicago

Ardeshirrouhanifard, Shirin, Sophie D Fossa, Robert Huddart, Patrick O Monahan, Chunkit Fung, Yiqing Song, M Eileen Dolan, et al. 2022. “Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.” Ear and Hearing 43 (3): 794–807. doi:10.1097/AUD.0000000000001172.